GoodRx Launches New Prescription Cost Tracker to Spotlight Key Factors Driving Out-of-Pocket Medication Costs in the U.S.
| GDRX Stock | USD 4.98 0.09 1.84% |
Slightly above 55% of Goodrx Holdings' investors are presently thinking to get in. The analysis of the overall investor sentiment regarding Goodrx Holdings suggests that some traders are interested. Goodrx Holdings' investing sentiment can be driven by a variety of factors including economic data, Goodrx Holdings' earnings reports, geopolitical events, and overall market trends.
Goodrx |
Today, GoodRx , the leading prescription savings platform in the U.S., debuted its new Prescription Cost Tracker where it will monitor o
Read at businesswire.com
 |
Goodrx Holdings Fundamental Analysis
We analyze Goodrx Holdings' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Goodrx Holdings using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Goodrx Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Book Value Per Share
Book Value Per Share Comparative Analysis
Goodrx Holdings is currently under evaluation in book value per share category among its peers. Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
Goodrx Holdings Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Goodrx Holdings stock to make a market-neutral strategy. Peer analysis of Goodrx Holdings could also be used in its relative valuation, which is a method of valuing Goodrx Holdings by comparing valuation metrics with similar companies.
Peers
Goodrx Holdings Related Equities
| HCAT | Health Catalyst | 6.38 | ||||
| TALK | Talkspace | 4.00 | ||||
| EVH | Evolent Health | 3.57 | ||||
| DOCS | Doximity | 1.51 | ||||
| HSTM | HealthStream | 1.50 | ||||
| VEEV | Veeva Systems | 1.43 | ||||
| TDOC | Teladoc | 0.63 | ||||
| NRC | National Research | 0.62 | ||||
| SDGR | Schrodinger | 0.27 | ||||
| ACCD | Accolade | 0.14 | ||||
| AMWL | American Well | 0.50 | ||||
| SLP | Simulations Plus | 0.79 | ||||
| TXG | 10X Genomics | 0.83 | ||||
| PGNY | Progyny | 1.53 | ||||
| PRVA | Privia Health | 1.92 | ||||
| GEHC | GE HealthCare | 2.29 | ||||
| CERT | Certara | 3.39 | ||||
| DH | Definitive Healthcare | 34.35 |
Additional Tools for Goodrx Stock Analysis
When running Goodrx Holdings' price analysis, check to measure Goodrx Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Goodrx Holdings is operating at the current time. Most of Goodrx Holdings' value examination focuses on studying past and present price action to predict the probability of Goodrx Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Goodrx Holdings' price. Additionally, you may evaluate how the addition of Goodrx Holdings to your portfolios can decrease your overall portfolio volatility.